Companies similar to CABALETTA BIO INC (CABA)
Health Care · NASDAQ
CABALETTA BIO INC (CABA)'s closest peers include KYVERNA THERAPEUTICS INC (KYTX), INTELLIA THERAPEUTICS INC (NTLA), CRISPR THERAPEUTICS AG (CRSP), Bristol Myers Squibb (BMY), NOVARTIS AG (NVS) and Gilead Sciences (GILD). This peer set is drawn from CABA's enriched company profile and is informational only — not financial advice.
Similar companies
-
KYVERNA THERAPEUTICS INCKYTXHealth Care
Kyverna is a clinical-stage immunology biotech developing novel investigational therapeutics with no approved products and complete dependence on successful…
$7.48 (as of 2026-07-21) · market cap $440M
-
INTELLIA THERAPEUTICS INCNTLAHealth Care
CRISPR-based genome editing company developing in vivo therapies for rare genetic diseases including hereditary angioedema and ATTR amyloidosis.
$11.47 (as of 2026-07-21) · market cap $1.6B
-
CRISPR THERAPEUTICS AGCRSPHealth Care
CRISPR Therapeutics develops gene-editing medicines using CRISPR/Cas9 technology, with the first approved CRISPR therapy (CASGEVY) for sickle cell disease and…
$48.15 (as of 2026-07-21) · market cap $4.6B
-
Bristol Myers SquibbBMYHealth Care
Bristol Myers Squibb is a leading biopharmaceutical company specializing in advanced oncology, immunology, and cardiovascular therapies using diverse…
$60.93 (as of 2026-07-21) · market cap $123.2B
-
NOVARTIS AGNVS
Global pharmaceutical and biotechnology company pioneering disease-modifying treatments across oncology, immunology, neuroscience, and rare genetic diseases.
$153.87 (as of 2026-07-21) · market cap $228.2B
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$130.28 (as of 2026-07-21) · market cap $161.3B
Not quite? Describe exactly what you want →
Peers are drawn from CABA's enriched profile (the same similarity signal the chat uses for "companies like CABA"). See the full profile: CABALETTA BIO INC (CABA).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.